These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S. J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937 [Abstract] [Full Text] [Related]
3. Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis. Dahl R, Stender A, Rak S. Allergy; 2006 Feb; 61(2):185-90. PubMed ID: 16409194 [Abstract] [Full Text] [Related]
11. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children. Valovirta E, Jacobsen L, Ljørring C, Koivikko A, Savolainen J. Allergy; 2006 Oct; 61(10):1177-83. PubMed ID: 16942565 [Abstract] [Full Text] [Related]
12. Design and recruitment for the GAP trial, investigating the preventive effect on asthma development of an SQ-standardized grass allergy immunotherapy tablet in children with grass pollen-induced allergic rhinoconjunctivitis. Valovirta E, Berstad AK, de Blic J, Bufe A, Eng P, Halken S, Ojeda P, Roberts G, Tommerup L, Varga EM, Winnergard I, GAP investigators. Clin Ther; 2011 Oct; 33(10):1537-46. PubMed ID: 21999887 [Abstract] [Full Text] [Related]
13. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. Rolinck-Werninghaus C, Wolf H, Liebke C, Baars JC, Lange J, Kopp MV, Hammermann J, Leupold W, Bartels P, Gruebl A, Bauer CP, Schnitker J, Wahn U, Niggemann B. Allergy; 2004 Dec; 59(12):1285-93. PubMed ID: 15507097 [Abstract] [Full Text] [Related]